Algorae Pharmaceuticals Ltd

Company Profile

• Business description

  Algorae Pharmaceuticals Ltd is an AI-enabled pharmaceutical company operating a synergistic dual-track business comprising AI-driven drug discovery and pharmaceutical commercialization. Its discovery activities are built around AlgoraeOS, its proprietary artificial intelligence (AI) drug-combination prediction platform, developed in collaboration with the UNSW AI Institute with support from CSIRO Data61, together with a therapeutic pipeline comprising AI-116 for dementia and AI-168 for cardiovascular disease. Its commercial activities are conducted through its wholly owned subsidiary, which sources, licenses, registers and supplies generic and specialty medicines in Australia and New Zealand through partnered manufacturers and established distribution channels.

• Contact

  525 Collins Street
  Level 23, Rialto South Tower
  MelbourneVIC3000
  AUS

  T: +61 422180317

  https://www.algoraepharma.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  Employees

  48